Histological changes of the mammary tissues during the growth of pregnancy-dependent mammary tumors (PDMT) and the immunohistochemical staining of epidermal growth factor (EGF) in these mammary epithelial cells were studied in the inbred strain of GR/A mice. Mice were mated at 60-70 days of age and subjected to concurrent pregnancy. Mice developing PDMT at the first pregnancy always retained the microscopically detectable tumors during the subsequent inter-or early pregnancy when no gorss PDMT existed. EGF staining was observed in the epithelial cells of the lactating mammary glands showing marked proliferation, but not in PDMT. These findings demonstrate that in GR/A mice PDMT repeat growth and regression, but not the complete extinction, during the reproduction and suggest that the contribution of EGF to the growth of PDMT is rather minor.
The GR/A strain of mice is characterized by pregnancy-dependent mammary tumors (PDMT), of which development and growth are largely dependent upon reproductive activity. This type of tumor becomes palpable after the middle of pregnancy, reaches maximal size at the end of pregnancy, and regresses soon after parturition irrespective of lactation and appears again during the subsequent pregnancy (1, 11) . While both progesterone and estrogen participate in the development and growth of PDMT, progesterone is known to be a key hormone for DNA synthesis of the tumors (19).
Epidermal growth factor (EGF) is known to be a mitogenic polypeptide affecting proliferation of a variety of cells (3) and its receptor has been subjected to intense studies in relation to cancer biology because of its homology to the transforming protein encoded by the avian oncogene v-erb B (4). Evidence of a role of EGF in the growth of mammary epithelia has come from a number of works; i. e. the stimulative effects of EGF on the development of the mammary gland during pregnancy and lactation (5, 8), tumorigenesis of the mammary gland in rodents (9), and maintenance of primary mammary epithelial cell cultures of rodent or human origin (17). Therefore, it is of interest to examine the relationship between the growth of PDMT and the change of EGF activity in GR/A mice. In this study, we examined the changes in the histology and immunohistochemical EGF staining in the normal mammary glands and PDMT of GR/A mice at various stages of pregnancy. donated by Drs. L.M. Boot and G. Ropcke, the Netherlands Cancer Institute, Amsterdam, the Netherlands, and maintained in our laboratory by strict brother-to-sister mating. Virgin females were mated with males at 60-70 days of age. The day when copulation plug was found was designated as day 1 of pregnancy and some mice developing PDMT were killed on day 18-19 of pregnancy. Three days before delivery, other pregnant females were placed again with males to induce concurrent pregnancy. Each pregnant mouse was palpated every day during the last few days of pregnancy for PDMT, of which site was confirmed. On the day of delivery, litter size was adjusted to 6 and mice were allowed to lactate their pups normally until killing. Only mice that developed PDMT at the 1st pregnancy and achieved concurrent pregnancy were used. II) Tissue sample:
Mammary glands were removed together with palpable or rudimentary PDMT on days 19-20 of the 1st pregnancy (late pregnancy; LP), days 1-3 of lactation (early lactation; EL), days 5-8 of the 2nd pregnancy and lactation (early-pregnancy and lactation; EPL) and days 10-14 of the 2nd pregnancy and lactation (mid-pregnancy and lactation; MPL) ( Fig. 1) . At EPL and MPL, special caution was paid to obtain the portions of the glands around which PDMT had developed during the preceding pregnancy and confirmed histologically the presence of rudimentary PDMT.
Tissues were fixed in 10% formalin, embedded in 
RESULT
Normal mammary glands were represented by ducts lined with two or three layers of cuboidal cells and small alveoli lined with a single layer of cuboidal epithelial cells.
During pregnancy, the epithelial cells of the mammary gland underwent a pronounced hypertrophy; the alveoli were widely distended with milk accumulated in the lumina and the ducts were also dilated (Fig. 2) .
During lactation, the glands consisted almost entirely of glandular tissue; the lumina of alveoli were markedly dilated by milk and most of the interlobular connective tissue disappeared (Fig. 3) .
PDMT were composed of diversified groups of the epithelial patterns: acinar structure, intracystic papillary projections, irregular cords and tubes, and solid sheets of proliferated epithelial cells at the late pregnancy (Fig. 2) . On the other hand, microscopical examination of the serial sections of the mammary glands around which PDMT had developed during the preceding pregnancy revealed that the mammary tissues constantly contained the rudimentary state of PDMT at the early-or mid-pregnancy (Figs. 3, 4) .
In the immunocytological staining, positive reaction of EGF was mostly observed in the normal mammary epithelial cells only of the early-or mid-pregnancy and lactation (EPL and MPL), but little in those of the 1st late pregnancy and early lactation (LP and EL) ( Table 1) . While these EGF-positive cells showed different intensity of staining, the staining was uniformly distributed throughout the cytoplasm (Fig.  5) . Slight EGF staining was seen in some luminal contents in the lactating mammary glands. However, PDMT and their rudiments were characterized by no reaction product for EGF (Table 1, Fig. 6 ).
DISCUSSION
The present study shows that the mammary glands of GR/A female mice retain the microscopically detectable rudiments of PDMT even after their postpartum regression. This would be the first report demonstrating that this type of tumors repeats only the regression and growth during reproduction, but not extincts itself completely at each pregnancy. The mechanism in this process remains to be solved.
EGF appears to be an important regulator of the proliferation of mouse mammary gland both in vivo (18) and in vitro (12). While concentration of EGF is known to increase in both sera and submandibular glands during the course of pregnancy and lactation in mice (8), high concentration is found in milk of the mammary glands (2). Izuno et al. (7) have stated that order to check the antigen specificity, a primary EGF antibody was absorbed with excess mouse EGF (Product No. E 0765, Sigma). After incubation for 3 hr at room temperature, the antibody-antigen mixture was centrifuged at 3,000 rpm for 20min. The supernatant was tested by incubating mammary and submandibular glands of SHN female mice, and negative staining was observed. EGF is also a mitogen for several breast cancer cell lines (6) and some breast tumors express high levels of the receptor protein as evidenced by EGF binding or immunohistochemical staining (14). In this study, PDMT responded little to EGF staining, which may be unexpected. However, there is a significantly reverse relationship between the presence of EGF receptor and that of estrogen receptor (10, 14). PDMT were found to contain receptors to both estrogen and progesterone (15) and the receptor levels of progesterone and prolactin were much higher in PDMT than in the normal mammary glands (13). Furthermore, PDMT showed much higher responsiveness to mammotropic hormones than did normal mammary glands (19). These strongly suggest that the contribution of EGF to the growth of PDMT, which are the benign tumors, is rather minor, whereas it may be an important role in the transformation of normal cells to PDMT. 
